LONG-TERM EFFECTS OF ETANERCEPT AND CERTOLIZUMAB PEGOL TREATMENT ON VASCULAR FUNCTION AND LIPID PARAMETERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS

被引：2
|
作者：
Vegh, Edit [1 ]
Vancsa, Andrea [1 ,2 ]
Kerekes, Gyoergy
Balazs, Fruzsina [1 ]
Pogacsas, Lilla [1 ]
Bodnar, Nora [1 ]
Szuecs, Gabriella [1 ]
Szanto, Sandor [1 ]
Szekanecz, Zoltan [1 ]
机构：
[1] Univ Debrecen, Med & Hlth Sci Ctr, Inst Med, Dept Rheumatol, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Dept Angiol, H-4012 Debrecen, Hungary
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2013-205124.82
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1.83
引用
收藏
页码：A36 / A37
页数：6
相关论文
共 50 条
  • [1] LONG-TERM EFFECTS OF ETANERCEPT AND CERTOLIZUMAB PEGOL TREATMENT ON VASCULAR FUNCTION AND LIPID PARAMETERS IN RHEUMATOID ARTHRITIS
    Vegh, E.
    Kerekes, G.
    Vancsa, A.
    Balazs, F.
    Pogacsas, L.
    Pal, I.
    Szanto, S.
    Szuecs, G.
    Szekanecz, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 411 - 411
  • [2] LONG-TERM EFFECTS OF ETANERCEPT TREATMENT ON VASCULAR FUNCTION AND LIPID PARAMETERS IN ANKYLOSING SPONDYLITIS
    Bodnar, N.
    Kerekes, G.
    Vegh, E.
    Gulyas, K.
    Balazs, F.
    Pogacsas, L.
    Pal, I.
    Szekanecz, Z.
    Szanto, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 958 - 958
  • [3] Certolizumab in the long-term treatment of rheumatoid arthritis
    Khan, Abdul
    Scott, David L.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2011, 3 : 63 - 71
  • [4] Long-Term Maintenance of Response in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol
    Saraux, Alain
    Flipo, Rene-Marc
    Fagnani, Francis
    Cukierman, Gabrielle
    Bru, Isabelle
    Joubert, Jean-Michel
    Schuller, Jan-Christof
    Massol, Jacques
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
    Miguel Senabre-Gallego, Jose
    Santos-Ramirez, Carlos
    Santos-Soler, Gregorio
    Salas-Heredia, Esteban
    Sanchez-Barrioluengo, Mabel
    Barber, Xavier
    Rosas, Jose
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 961 - 972
  • [6] SAFETY UPDATE ON CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH LONG-TERM EXPOSURE
    Mariette, X.
    van Vollenhoven, Ronald F.
    Bykerk, V.
    de Longueville, M.
    Arendt, C.
    Luijtens, K.
    Cush, J.
    RHEUMATOLOGY, 2013, 52 : 86 - 86
  • [7] Health-related quality of life in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated with certolizumab pegol
    Sarobe, Maite
    Arrondo, Amaya
    Ibarrondo, Oliver
    Mar, Javier
    FARMACIA HOSPITALARIA, 2022, 46 (01) : 27 - 30
  • [8] EVALUATION OF COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL COMPARED WITH ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN COLOMBIA
    Guzman, R.
    Jaramillo, L. F.
    Otero, W.
    VALUE IN HEALTH, 2013, 16 (07) : A717 - A717
  • [9] Long-Term Effects of Comprehensive Inpatient Rehabilitation on Function and Disease Activity in Patients with Chronic Rheumatoid Arthritis and Ankylosing Spondylitis
    Ayhan, Figen
    Gecene, Muharrem
    Gunduz, Rukiye
    Borman, Pinar
    Yorgancioglu, Rezan
    TURKISH JOURNAL OF RHEUMATOLOGY, 2011, 26 (02) : 135 - 144
  • [10] Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
    Fleischmann, Roy
    van Vollenhoven, Ronald F.
    Vencovsky, Jiri
    Alten, Rieke
    Davies, Owen
    Mountian, Irina
    de Longueville, Marc
    Carter, David
    Choy, Ernest
    RHEUMATOLOGY AND THERAPY, 2017, 4 (01) : 57 - 69
12345